KDEV) today announces that its portfolio company Dilafor has successfully completed regulatory meetings with the U.S. Food and Drug Administration, FDA, and European Health Agencies, regarding the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback